In this episode, recorded on the eve of MAPS’ Psychedelic Science 2023, Kyle interviews MAPS’ Founder and President, Rick Doblin, Ph.D. He begins with an overview of the fast-approaching (and largest ever) psychedelics conference, emphasizing its significant growth, many features, and bipartisan opening ceremony, then discusses MAPS’ soon-to-be-released confirmatory Phase III data on MDMA-assisted therapy […]
The post PT428 – The Promise of MAPS’ Phase III Data, Psychedelics and Adolescents, and the Need for Honest Drug Education appeared first on Psychedelics Today.
